Table 4.
Ongoing clinical trials of phage.
| Name of the study | Phase | Registry date | Clinical trial registry number | Trial result | Public data |
|---|---|---|---|---|---|
| A phase 1b/2 trial of the safety and microbiological activity of bacteriophage therapy in Cystic fibrosis subjects colonized with Pseudomonas aeruginosa | I/II | 12 July 2022 | NCT05453578 | – | Trial design (168) |
| Cystic Fibrosis bacteriophage study at Yale (CYPHY) | I/II | 24 December 2020 | NCT04684641 | – | Trial design (169) |
| A randomized, placebo-controlled, double-blind clinical trial of therapeutic bacteriophage preparation in chronic antibiotic-resistant wound infections at Banaras Hindu University, Varanasi, India. | I/II | 8 December 2021 | CTRI/2021/12/038527 | – | Trial design (170) |
| Phage Therapy for the treatment of urinary tract infection | I/II | 13 September 2022 | NCT05537519 | – | Trial design (171) |